Can a pharmacy bundle shorten ICU stays and cut costs?

NCT ID NCT02924844

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether adding a set of pharmacist-led activities (a 'clinical pharmacy bundle') could improve outcomes for nearly 2,800 ICU patients in two French hospitals. Researchers compared patient data before and after the bundle was introduced, focusing on length of hospital stay, ICU stay, and costs. The goal was to see if this approach could lead to better care and lower expenses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
clinical pharmacy bundle (a set of pharmacist-led care activities)
What this could lead to
If effective, this bundle could become a standard way to improve ICU patient outcomes and reduce hospital costs.
What could go wrong
This is an observational before-after study, not a randomized trial, so results may be influenced by other changes over time. It may not apply to other ICUs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTENSIVE CARE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Nîmes

    Nîmes, Gard, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.